Barely Significant
← all excerpts

Lupus pathobiology based on genomics.

Immunogenetics · 2017 · PMC5203839 · PMID 27933432

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

barely significantP = 0.053so close (0.05 < p ≤ 0.1)
A subsequent randomized, double-blind, placebo-controlled study of sifalimumab was barely significant ( P = 0.053; though the a priori cutoff for this trial was unconventionally P = 0.1), and there was no clear dosage effect (Khamashta et al. 2016 ).

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.